WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in IRWD — Ironwood Pharmaceuticals Inc

CIK 1632972 PLYMOUTH, MN

Back to IRWD Full portfolio

Position in IRWD

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$923,863

+$128,189 QoQ

Shares Held

219,445

-3.2% QoQ

Ownership

0.133%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 11 holders

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 2.0264758823395383.ToString("F0")% Shared 0.ToString("F0")% None 97.97352411766046.ToString("F0")%

Common Shares in IRWD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $45,863,285 across 32 Drug Manufacturers - Specialty & Generic names. IRWD ranks #7 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	71,595	$12,066,621
2	UTHR	UNITED THERAPEUTICS Corp	16,933	$9,174,807
3	ZTS	Zoetis Inc.	83,719	$6,016,047
4	VTRS	Viatris Inc	362,617	$5,758,357
5	KNSA	Kiniksa Pharmaceuticals International, plc	20,499	$1,310,911
6	AMRX	Amneal Pharmaceuticals, Inc.	59,123	$1,023,419
7	IRWD	Ironwood Pharmaceuticals Inc This page	219,445	$923,863
8	LNTH	Lantheus Holdings, Inc.	7,760	$860,894

All Filings in IRWD

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$923,863	219,445	-3.2%	Shares	Sole	2026-07-15
2026-03-31	$795,674	226,688	+45.8%	Shares	Sole	2026-04-08
2025-12-31	$524,112	155,523	+0.7%	Shares	Sole	2026-01-08
2025-09-30	$202,248	154,388	+23.1%	Shares	Sole	2025-10-29
2025-06-30	$90,331	125,460	+425.2%	Shares	Sole	2025-07-10
2025-03-31	$35,112	23,886	+80.5%	Shares	Sole	2025-04-16
2024-12-31	$58,631	13,235	-2.7%	Shares	Sole	2025-03-17
2024-06-30	$88,724	13,608	—	Shares	Sole	2024-07-16
No filing history on record for this holder in this stock.